Article info
Pancreatic tract
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis
- Mr C D Johnson, Reader in Surgery, Southampton General Hospital (Mail point 816), Southampton SO16 6YD, UK.c.d.johnson{at}soton.ac.uk
Citation
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis
Publication history
- Accepted June 22, 2000
- First published January 1, 2001.
Online issue publication
January 10, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
British Society of Gastroenterology